FDA Approves Pfizer COVID Vaccine Booster for Seniors and Frontline Workers

​
​Last week on September 22, the U.S. Food and Drug Administration (FDA) approved the Pfizer COVID-19 vaccine booster shot for select groups - including seniors and frontline workers. The Centers for Disease Control (CDC) recommends that the following groups should receive a booster shot: ​

---

• people aged 65+
• residents aged 18 years and older in long-term care settings

• people aged 18–64 years with underlying medical conditions
• people aged 18–64 years at increased risk for COVID-19 exposure and transmission because of an occupational or institutional setting (i.e. frontline workers)

​
Only individuals who were initially vaccinated with the Pfizer COVID vaccine can receive the Pfizer booster shot at this time. 

Click here to learn more about the COVID booster shots from the CDC website.